Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Oct 2016)

Effect of High (200 μg/kg per Minute) Adenosine Dose Infusion on Fractional Flow Reserve Variability

  • Dimitrios Alexopoulos,
  • Ioanna Xanthopoulou,
  • Grigorios Tsigkas,
  • Nikolaos Koutsogiannis,
  • Paraskevi Salata,
  • Stylianos Armylagos,
  • Athanasios Moulias,
  • Periklis Davlouros

DOI
https://doi.org/10.1161/JAHA.116.004323
Journal volume & issue
Vol. 5, no. 11

Abstract

Read online

BackgroundVariations in distal coronary pressure (Pd)/aortic pressure (Pa) ratio during steady‐state hyperemia with standard (140 μg/kg per minute) adenosine dose may hamper accurate fractional flow reserve assessment. This study investigated to what extent an increased adenosine dose can overcome Pd/Pa variation. Methods and ResultsIn a prospective, single‐arm study, out of 95 prospectively screened patients, 38 (40.0%) exhibited significant (≥0.05 difference of max Pd/Pa minus min Pd/Pa) variations in Pd/Pa from 15 s post Pd/Pa dip and until the end of a 3‐minute adenosine (140 μg/kg per minute) infusion. Thirty patients agreed to participate in a post 5‐minute repeat fractional flow reserve assessment using 200 μg/kg per minute 3‐minute adenosine infusion. The study's co‐primary end point of Pd/Pa coefficient of dispersion was lower for the high versus standard adenosine dose: 1.31 (1.13–2.72) versus 2.76 (2.38–5.60), P=0.002. The study's co‐primary end point of ΔPd/Pa was also lower for the high versus standard adenosine dose: 0.065 (0.038–0.10) versus 0.08 (0.06–0.11), P=0.002. This difference was mainly driven by the lowering effect of the high adenosine dose on the maximum Pd/Pa compared to the standard dose: 0.84 (0.81–0.93) versus 0.90 (0.83–0.95), P=0.007, while minimum Pd/Pa remained unaffected. High adenosine dose was adequately tolerated by all patients, without requiring infusion discontinuation in any case. ConclusionsPd/Pa variability is frequently observed during standard adenosine infusion and is significantly decreased following a high (200 μg/kg per minute) adenosine dose. This is achieved without a significant difference in the minimum Pd/Pa. Clinical Trial RegistrationURL: https://www.clinicaltrials.gov. Unique identifier: NCT02350439.

Keywords